Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07399613 · ClinicalTrials.gov registry record · NA
Effects of Protective Step Training on Proactive and Reactive Motor Adaptations in Parkinson's Disease Patients
A NA study of Parkinson Disease and Fall, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07399613: Completed NA study of Parkinson Disease and Fall, sponsored by Arizona State University.
NCT07399613 is a NA study of Parkinson Disease and Fall that has completed, run by Arizona State University. The registered enrollment target is 12 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07399613, a NA study of Parkinson Disease and Fall, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study was to investigate to what extent PD affects the ability to walk, respond to balance perturbations (i.e., Protective Step Training) and produce acute short-term effects to improve compensatory reactions and control of unperturbed walking balance.
Primary Outcome
Joint (knee) Reaction time during standing and walking perturbations.
Conditions Studied
Interventions
- BEHAVIORAL Protective Step Training
Study Locations (1)
Arizona
- Glencroft Senior Living: Retirement Community in Arizona - Glendale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-01-19 |
| Est. Completion | 2023-03-18 |
| Phase | NA |
What the finished NCT07399613 record still lists
NCT07399613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Protective Step Training is the first listed.
NCT07399613 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT07399613 about?
NCT07399613 is a clinical study titled "Effects of Protective Step Training on Proactive and Reactive Motor Adaptations in Parkinson's Disease Patients". The aim of this study was to investigate to what extent PD affects the ability to walk, respond to balance perturbations (i.e., Protective Step Training) and produce acute short-term effects to improve compensatory reactions and control of unperturbed walking balance.
What is the current status of trial NCT07399613?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-01-19. Estimated completion is 2023-03-18.
What conditions does trial NCT07399613 study?
This clinical trial studies the following conditions: Parkinson Disease, Fall, Accidental Falls, Protective Step Training, Falls, Intervention.
What interventions are being tested in trial NCT07399613?
The interventions under investigation include: Protective Step Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07399613?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07399613 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07399613's enrollment target sits among peer trials
12 268th of 297 higher than 24 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI